Your browser doesn't support javascript.
loading
The glycosphingolipid P1 is an ovarian cancer-associated carbohydrate antigen involved in migration.
Jacob, F; Anugraham, M; Pochechueva, T; Tse, B W C; Alam, S; Guertler, R; Bovin, N V; Fedier, A; Hacker, N F; Huflejt, M E; Packer, N; Heinzelmann-Schwarz, V A.
Afiliación
  • Jacob F; 1] Gynecological Research Group, Department of Biomedicine, University Hospital Basel, University of Basel, Hebelstrasse 20, Basel 4031, Switzerland [2] Ovarian Cancer Group, Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales, Prince of Wales Clinical School, Building C
  • Anugraham M; Department of Chemistry and Biomolecular Sciences, Biomolecular Frontiers Research Centre, Faculty of Science, Macquarie University, Balaclava Road, North Ryde, Sydney, NSW 2109, Australia.
  • Pochechueva T; Gynecological Research Group, Department of Biomedicine, University Hospital Basel, University of Basel, Hebelstrasse 20, Basel 4031, Switzerland.
  • Tse BW; 1] Ovarian Cancer Group, Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales, Prince of Wales Clinical School, Building C25 Kensington Campus, Sydney, NSW 2052, Australia [2] Australian Prostate Cancer Research Centre Queensland, Institute of Health and Biomedical Innova
  • Alam S; Gynecological Research Group, Department of Biomedicine, University Hospital Basel, University of Basel, Hebelstrasse 20, Basel 4031, Switzerland.
  • Guertler R; 1] Gynecological Research Group, Department of Biomedicine, University Hospital Basel, University of Basel, Hebelstrasse 20, Basel 4031, Switzerland [2] Ovarian Cancer Group, Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales, Prince of Wales Clinical School, Building C
  • Bovin NV; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Ul. Miklukho-Maklaya, 16/10, Moscow 117997, Russian Federation.
  • Fedier A; Gynecological Research Group, Department of Biomedicine, University Hospital Basel, University of Basel, Hebelstrasse 20, Basel 4031, Switzerland.
  • Hacker NF; Gynaecological Cancer Centre, Royal Hospital for Women, School of Women's and Children's Health, Barker Street, Randwick, NSW 2031, Australia.
  • Huflejt ME; Division of Thoracic Surgery and Thoracic Oncology, Department of Cardiothoracic Surgery, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.
  • Packer N; Department of Chemistry and Biomolecular Sciences, Biomolecular Frontiers Research Centre, Faculty of Science, Macquarie University, Balaclava Road, North Ryde, Sydney, NSW 2109, Australia.
  • Heinzelmann-Schwarz VA; 1] Gynecological Research Group, Department of Biomedicine, University Hospital Basel, University of Basel, Hebelstrasse 20, Basel 4031, Switzerland [2] Ovarian Cancer Group, Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales, Prince of Wales Clinical School, Building C
Br J Cancer ; 111(8): 1634-45, 2014 Oct 14.
Article en En | MEDLINE | ID: mdl-25167227
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Glicoesfingolípidos / Antígenos de Neoplasias / Metástasis de la Neoplasia Tipo de estudio: Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Glicoesfingolípidos / Antígenos de Neoplasias / Metástasis de la Neoplasia Tipo de estudio: Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido